Clinical Trial Results:
GISSI AF Randomized, prospective, parallel group, placebo-controlled, multi-center study on the use of valsartan an angiotensin II AT1-receptor blocker in the prevention of Atrial Fibrillation recurrence
Summary
|
|
EudraCT number |
2004-003036-53 |
Trial protocol |
IT |
Global completion date |
22 Apr 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 Mar 2020
|
First version publication date |
20 Mar 2020
|
Other versions |
|
Summary report(s) |
GISSI-AF Results - Part 1 GISSI-AF Results - Part 2 GISSI-AF Results - Part 3 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.